Wednesday, November 30, 2022

Add-on empagliflozin boosts quality of life in T2D, hypertension

Add-on empagliflozin boosts quality of life in T2D, hypertension

Using empagliflozin as add-on therapy helps patients with type 2 diabetes and hypertension with quality-of-life improvements, such as general health, physical endurance, food satisfaction, emotional and mental health, symptom botherness and treatment satisfaction, suggests a study in the Indian Journal of Public Health. It also significantly improved their A1C, postprandial glucose, systolic blood pressure, fasting blood pressure and diastolic blood pressure levels.

Full Story: Medical Dialogues (11/28) 


No comments:

Post a Comment